The group said in a statement that the recall applies only to a large number of tablets to 40 mg Lipitor. The action was initiated after the company received reports of strange smells from the bottle where the pills were packaged.
According to the company these bottles have been supplied by a subcontractor and third Pfizer has already identified the source. The name of the contractor is not revealed in the statement of the company.
Pfizer's decision to 19,000 bottles of its cholesterol drug Lipitor, which is also used to reduce the risk of heart disease recall is the result of "increased supervision issues related to the smell of other reports by the industry."
The continuing retreat Lipitor is already the fourth in 2010. There were three previous similar actions by the company in August, October and November, often in response to complaints of strange odors have been.
Pfizer says that the health risks associated with the odor is minimal. This odor comes from particles of a fungicide (2,4,6-tribromoanisole) "found in very small amounts in the bottle because of the appeal." This odor was the reason for the removal, first mentioned above.
This special perfume and helps the wood pallets on which goods are transported and stored to protect. However, Pfizer said that "the use of Pfizer treated wood with TBP in the supply of drugs bans theirs." The company said that this point was contained before the ban on the use of treated wood pallets for doctors CSA programs.
Pfizer claims taken "strong measures" have to avoid problems with smell in the future.
Lipitor, a cholesterol-lowering drug, is offered one of the most active drugs and sold worldwide. According to AFP report sales of more than $ 10,000,000 per year.
According to the company these bottles have been supplied by a subcontractor and third Pfizer has already identified the source. The name of the contractor is not revealed in the statement of the company.
Pfizer's decision to 19,000 bottles of its cholesterol drug Lipitor, which is also used to reduce the risk of heart disease recall is the result of "increased supervision issues related to the smell of other reports by the industry."
The continuing retreat Lipitor is already the fourth in 2010. There were three previous similar actions by the company in August, October and November, often in response to complaints of strange odors have been.
Pfizer says that the health risks associated with the odor is minimal. This odor comes from particles of a fungicide (2,4,6-tribromoanisole) "found in very small amounts in the bottle because of the appeal." This odor was the reason for the removal, first mentioned above.
This special perfume and helps the wood pallets on which goods are transported and stored to protect. However, Pfizer said that "the use of Pfizer treated wood with TBP in the supply of drugs bans theirs." The company said that this point was contained before the ban on the use of treated wood pallets for doctors CSA programs.
Pfizer claims taken "strong measures" have to avoid problems with smell in the future.
Lipitor, a cholesterol-lowering drug, is offered one of the most active drugs and sold worldwide. According to AFP report sales of more than $ 10,000,000 per year.
No comments:
Post a Comment